is there a shortage of semaglutide Makers compounded Wegovy, Ozempic threatened by FDA move If Ozempic Is in Short

Market analysis shows the global obesity GLP-1 market was valued at about USD 8.21 billion in 2025 and is expected to reach roughly USD 66.57 billion by 2035, expanding at a CAGR of about 23% due to rising obesity rates and strong clinical effectiveness of GLP-1 drugs

Liraglutide has been recognized for its role in controlling appetite and glucose levels, while GLP-1 is noted for its higher potency and longer duration of action

Comparison to BPC-157 : Much less targeted for specific injuries

Essentially, this means that a good deal of the glutathione you ingest is actually expelled from the body before it can be used